Improved EU Pharmacovigilance May Not Prevent Another Mediator
This article was originally published in The Pink Sheet Daily
Executive Summary
The affair surrounding Servier's withdrawn Mediator drug highlights serious loopholes in the new EU pharmacovigilance system.